Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer
Science Advances · 13.03.2026 · 12 (11)
DOI: 10.1126/sciadv.aea6225 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 13.03.2026. Verfasst von Amanda Luvisotto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, American Cancer Society.
Abstract (Originalsprache)
Small cell lung cancer (SCLC), accounting for ~15% of lung cancers, is an aggressive and lethal tumor type. It is characterized by rapid proliferation, early metastasis, and poor prognosis. Current therapies, including platinum-based chemotherapy and recently introduced immune checkpoint inhibitors, provide modest survival benefits due to frequent relapse and therapeutic resistance. At the molecular level, SCLC is marked by near-universal loss of the tumor suppressors genes TP53 and RB1 , and exhibits marked heterogeneity driven by several key master transcription factors. These factors define distinct molecular subtypes with unique gene expression programs and therapeutic vulnerabilities, enabling cell plasticity and subtype switching in response to treatment pressures. A thorough understanding of these subtype-specific dependencies and the epigenetic mechanisms regulating transcription is critical for developing effective and durable therapies. This review focuses on these aspects and evaluates the potential of epigenetic-targeted strategies in the treatment of SCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
- Simpson Querrey Center for Epigenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
ORCID-Profile: Amanda Luvisotto, Lu Wang
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- American Cancer Society
- U.S. Army Medical Research Acquisition Activity
- Department of Defense
Zitieren
APA
Luvisotto, A., Tulaiha, R., & Wang, L. (2026). Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. Science Advances, 12(11). https://doi.org/10.1126/sciadv.aea6225
Vancouver
Luvisotto A, Tulaiha R, Wang L. Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. Science Advances. 2026;12(11). doi:10.1126/sciadv.aea6225
BibTeX
@article{Luvisotto2026,
author = {Luvisotto, Amanda and Tulaiha, Rima and Wang, Lu},
title = {Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {11},
doi = {10.1126/sciadv.aea6225}
}
EUVIMED